
Cutera CUTR
Quarterly report 2024-Q3
added 11-12-2024
Cutera Interest Expense 2011-2026 | CUTR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -244 K | -4.3 M | -2.42 M | 68 K | -199 K | - | - | - | - | - | 455 K | 497 K | 614 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 614 K | -4.3 M | -692 K |
Quarterly Interest Expense Cutera
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 575 K | -387 K | - | -1.95 M | -453 K | -163 K | - | -876 K | -1.91 M | -611 K | - | -561 K | -392 K | 243 K | - | -382 K | 3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8 K | - | 138 K | 80 K | 105 K | 140 K | 75 K | 135 K | 105 K | 152 K | 144 K | 96 K | 140 K | 91 K | 199 K | 184 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 575 K | -1.95 M | -181 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
167 K | $ 32.67 | 5.42 % | $ 1.5 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.24 | 2.47 % | $ 1.65 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.36 | 3.2 % | $ 265 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 38.24 | 4.28 % | $ 5.7 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.61 | 0.13 % | $ 122 M | ||
|
Electromed
ELMD
|
78 K | $ 24.41 | 2.89 % | $ 206 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 91.72 | 1.91 % | $ 12.4 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.34 | -1.82 % | $ 125 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.89 | 3.28 % | $ 1.15 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 9.62 | 3.11 % | $ 741 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 178.59 | 7.02 % | $ 13.4 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 87.43 | 2.73 % | $ 3.04 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.18 | 2.63 % | $ 380 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 64.67 | 1.78 % | $ 3.53 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.67 | 0.71 % | $ 67.8 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Medtronic PLC
MDT
|
402 M | $ 88.04 | 1.87 % | $ 113 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.18 | 3.21 % | $ 885 M | ||
|
Myomo
MYO
|
-668 K | $ 0.68 | -0.3 % | $ 28.5 M | ||
|
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 9.84 | 1.76 % | $ 352 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 62.3 | 0.71 % | $ 92.2 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.45 | 3.76 % | $ 1.72 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.46 | 5.56 % | $ 1.13 B |